Endocyte Reports FDA Approves Radiographic Progression Free Survival As An Alternative Endpoint Of VISION Trial In Addition To Overall Survival, Co. Will Have A Conf. Call Today At 8:30 a.m. ET
Benzinga_Newsdesk